Conversely, NDNF+ interneurons showed normal Nav1.1 expression and activity in these mouse models, underscoring the distinct roles of different interneuron types in animal models that mimic some symptoms of Dravet Syndrome and highlighting VIP+ interneurons as potential future therapeutic targets. This evidence concerns the gene SCN1A and Dravet syndrome.